Curcumin Suppresses Colorectal Cancer Growth and Metastasis by Inhibiting NF-κB Activity
The third most malignant disease diagnosed worldwide is colorectal cancer (CRC). CRC treatment by chemo- and radiotherapy is challenging due to the cancer’s ability to activate major transcription factors such as NF-κB. Curcumin, a phytochemical, is known to downregulate NF-κB signaling in CRC cell lines and to exhibit anticarcinogenic properties. Therefore, curcumin and its analogues are novel therapeutic agents that could be used in the treatment of CRC growth and metastasis.
KeywordsColorectal cancer Curcumin NF-κB Growth
- 3.Koopman M, Venderbosch S, Van Tinteren H, Ligtenberg MJ, Nagtegaal I, Van Krieken JH, Punt CJ (2009) Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study. Eur J Cancer 45:1999–2006CrossRefPubMedGoogle Scholar
- 16.Nirmala MJ, Samundeeswari A, Sankar PD (2011) Natural plant resources in anti-cancer therapy-a review. Res Plant Biol 1:01–14Google Scholar